Ketoadd Tablet contains Alpha Ketoanalogue (NA), a specialized nutritional supplement primarily indicated for patients with chronic kidney disease (CKD) who require protein-restricted diets. Alpha Ketoanalogue serves as a nitrogen-free substitute for essential amino acids, helping to reduce the accumulation of nitrogenous waste products in the body, thereby alleviating uremic symptoms and slowing the progression of renal impairment. Ketoadd is utilized as an adjunct to dietary protein restriction to maintain adequate nutritional status while minimizing the metabolic burden on compromised kidneys. The tablet formulation ensures precise dosing and ease of administration. Clinical use of Ketoadd has demonstrated benefits in preserving lean body mass, reducing azotemia, and improving overall patient outcomes in CKD stages 3 to 5. It is important to administer Ketoadd under medical supervision, with careful monitoring of renal function, electrolyte levels, and nutritional parameters. Contraindications include hypersensitivity to any component of the formulation and severe hepatic impairment. Common adverse effects are generally mild and may include gastrointestinal discomfort. Ketoadd should be integrated into a comprehensive treatment plan including dietary management and regular nephrological evaluation to optimize therapeutic efficacy and patient safety.